Locations:
SearchAdvertisement
One-time infusion of adenovirus-based therapy is designed to restore heart muscle function
Studying gender-specific health factors promises new insight into diagnosis, prognosis, treatment
Consortium is uncovering risk factors that spur disease development in an understudied group
Authors discuss ethical challenges associated with sponsored genetic testing
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Discovery Accelerator Partnership with IBM Deploys Advanced Computing Technologies to Supercharge Healthcare Research
Cleveland Clinic researchers receive $2 million grant from the National Institutes of Health
Open-source artificial intelligence technology uses human genetic data to find candidate drugs
Network proximity and EHR analyses identify diabetes drug as a top candidate for risk reduction
Findings underscore need for racial diversity in ongoing and future trials
A case study in how pharmacogenomic testing can be helpful if not always essential
Advertisement
Advertisement